Arthrex Seeks High Court Review In $95M Loss On Surgical Method Patent

(November 12, 2015, 7:52 AM EST) -- WASHINGTON, D.C. — Asking for a review of a $95 million judgment, Arthrex Inc. argues in an Oct. 30 petition for a writ of certiorari to the U.S. Supreme Court that...
To view the full article, register now.